' /> ' /> ' />
A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Intensive Course Bookmark and Share

Intensive Course in Cancer Risk Assessment Overview

To help address the growing demand for clinicians with interdisciplinary knowledge and skills in the practice of genetic cancer risk assessment (GCRA), the multifaceted Intensive Course in Cancer Risk Assessment and its Clinical Cancer Genetics Community of Practice (CCGCoP) leverage the expertise of the academic health center through Web-based tools to deliver accessible, evidence-based cancer genetics and genomics training, professional development, and practice-centered support at the point of care. The mission of the Intensive Course and CCGCoP is to increase the number of clinicians who are able to translate rapid advances in genetics and genomics into cancer risk assessment, management, and prevention practice. Realizing the promise of personalized medicine by promoting best practices in the delivery of GCRA services across the U.S. and internationally is the ultimate goal of the Clinical Cancer Genetics Community of Practice.
 
 
Objectives
 
At the conclusion of the course the participants should be able to:
  • Integrate cancer genetics and oncology knowledge into clinical practice
  • Apply skills commensurate with practitioner-level proficiency into the cancer risk assessment and case management process
  • Recommend risk-appropriate options for cancer surveillance and prevention as part of the cancer risk assessment, including imaging, chemo preventive and surgical interventions
  • Incorporate understanding of medical, legal, and psychosocial ramifications of cancer risk counseling and testing into clinical practice and research collaboration
  • Discuss clinical research methodologies in cancer genetics epidemiology and cancer prevention trials for high-risk cohorts
  • Recognize the roles and practical issues related to Human Subjects Protections, Informed Consent, Institutional Review Board and HIPAA in clinical research
  • Provide resources and information on current hereditary cancer registries, cancer epidemiology and cancer prevention studies to patients and professional colleagues
  • Use research training and support to participate in collaborative research activities
  • Realize greater professional self-efficacy related to cancer risk counseling and research participation skills
  • Incorporate web-based resources into ongoing practice-based education, professional development and research network support
 
 
Reaching Clinicians Around the Globe
 
City of Hope's Intensive Course in Cancer Risk Assessment has trained health care professionals in community settings across the United States as well as in Argentina, Brazil, Canada, Chile, Columbia, Germany, Hong Kong, Mexico, Peru, Philippines, Puerto Rico, Spain, Taiwan, Turkey, and Uruguay. Participation of the Intensive Course alumni in the ongoing practice-centered professional development activities hosted by City of Hope has evolved into a dynamic international Clinical Cancer Genetics Community of Practice.
 
 

Accreditation

CME Credits
Accreditation Statement: Accreditation in process

Credit Designation: City of Hope designates this educational activity for a maximum of (TBD) AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The following may apply CME Category 1 credit for license renewal:

Registered Nurses: Nurses may report up to (TBD) credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). CME may be noted on the license renewal application in lieu of a BRN provider number.

Physician’s Assistants: The National Commission on Certification of Physician Assistants states that AMA accredited Category 1 courses are acceptable for CME requirements for recertification.

Genetic Counselor CEUs: The American Board of Genetic Counseling (ABGC) accepts CEUs approved by the National Society for Genetic Counselors (NSGC) for purposes of recertification. This event has been submitted to NSGC for approval of Category 1 CEUs and is approved for (TBD) CEUs and (TBD) Contact Hours.

Disclosure
The City of Hope adheres to ACCME Essential Areas, Standards for Commercial Support, and Policies regarding industry support of continuing medical education. Disclosure of the commercial relationships of everyone in a position to control content of an educational activity will be made at the activity. Speakers are also required to openly disclose discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
 
No partial credit will be given. Participants should claim only those hours of credit that they actually spent at the educational activity.
 

Intensive Course Application Requirement

Click image to apply.
Application Deadline
 
Enrollment for the 2015 Winter course will begin on June 20, 2014. The deadline will be August 1, 2014.
 
Requirements
Please read all terms stated below before submitting application.

To receive full course credit, and certificate of course completion, course participants will be required to:
 
  • Participate in all distance and on-campus course related activities.
  • Complete all distance learning lecture modules delivered via Website and USB drive (flashdrive) interface by given deadlines.
  • Complete all pre- and post-course surveys, knowledge questionnaires, evaluations, and assignments as directed.
  • Agree to complete prescribed post-course professional development activities as outlined in the course syllabus. Some activities are required to be completed at 6-months post training and some must be completed by 1-year post training.
 
Selection Criteria
Preferred candidates are oncology or genetics-trained physicians, advanced practice nurses and genetic counselors currently providing or planning to initiate community-based clinical cancer genetics services.
 
 
How to Apply
 
Complete the Intensive Course Application and submit the following:
 
  • Completed application form
  • Letter from your institution indicating that protected time will be provided for course participation, and statement that you will have institutional support to provide cancer risk assessment upon return to your community (if applicable).
  • Current curriculum vitae (CV)
  • Mini-biography
  • Current headshot
 
Please NOTE: Applications will not be accepted without the items listed above.
 
Submit all of the above via regular mail, email or fax to:
 
Gloria Nuñez, Conference Coordinator
City of Hope
Division of Clinical Cancer Genetics, Mod 173
1500 East Duarte Road
Duarte, CA 91010-3000

Fax:
626-930-5495

Email:
gnunez@coh.org (note subject as "Intensive Course")
 
Acceptance
Applicants will be notified of acceptance by September 30, 2014, via e-mail. The non-refundable course fee (TBD) will be due on or before October 31, 2014.
 

Faculty

Course Co-directors
Jeffrey Weitzel, M.D.
Director, Division of Clinical Cancer Genetics
and
Kathleen R. Blazer, Ed.D., M.S., L.C.G.C.
Assistant Director, Cancer Genetics Education Program

City of Hope Faculty
Danielle Castillo, BS
Cathy Cole, RNC, NP, MPH
Josef Herzog, BS
Robert Morgan, Jr., MD, FACP
Bita Nehoray, MS, LCGC
Mariana Niell-Swiller, MS, CGC
Lacolle Robinson, BA
Sharon Sand, BA, CCRP
Ilana Solomon, ScM, MS, CGC
April Sorrell, MD
Sharon Wilczynski, MD, PhD

Guest Faculty
Kimberly Banks, MS, CGC, Ambry Genetics
Julie Culver, MS, LCGC, USC Norris Comprehensive Cancer Center
Allan Ebbin, MD, MPH, UnitedHealthcare (retired)
Carin Espenschied, MS, LCGC, Ambry Genetics
Carol Fabian, MD, University of Kansas Cancer Breast Cancer Prevention and Survivorship Centers
Lucille Leong, MD, City of Hope
Katrina Lowstuter, MS, CGC, USC Norris Comprehensive Cancer Center
Deborah J. MacDonald, PhD, RN, APNG, (former CCG faculty)
Hazel Mariveles, BS, (former CCG staff)
Susan Neuhausen, PhD, University of California Irvine
Gloria Petersen, PhD, Mayo Clinic
Charité Ricker, MS, CGC, LAC+USC Medical Center

Administrative Staff
Gloria Nuñez, Conference Coordinator
Stacy Berger, Programmer Analyst
Larry Kiang, Technology Specialist
Tracy Sulkin, Education Assistant

Intensive Course Alumni

City of Hope's Intensive Course in Cancer Risk Assessment has trained health professionals in community settings across the United States as well as in Argentina, Brazil, Canada, Chile, Columbia, Germany, Hong Kong, Mexico, Peru, Philippines, Puerto Rico, Spain, Taiwan, Turkey, and Uruguay.

Intensive Course Description

The Intensive Course and Clinical Cancer Genetics Community of Practice embody the tenets of practice-centered situated learning theory. Distance delivery of a modular curriculum responds to the practical time constraints of working clinicians and allows for flexible, self-directed study (e.g., oncologists can opt out of basic oncology content and focus more study time on genetics content, etc.). Concurrent participation in Working Group Clinical Cancer Genetics Web conferences reinforces didactic learning and Genetic Cancer Risk Assessment (GCRA) skills development. Participants have the option of participating in one of four training tracks to customize training to meet their learning needs.
 
 
Click the individual track link below for more information, including fees, and to download the track Calendar for 2015 Winter (calendar in progress).
 
 
All four tracks include distance didactic learning with corresponding Web conference reviews, and case-based training with Working Group Web conferences. Only Track 1 Full Spectrum Multi-modal Training includes four days of face-to-face program development workshops.
 
Upon completion of training, all participants receive support to apply new learning to practice through 12 months of self-directed engagement and activities as members of the Clinical Cancer Genetics Community of Practice.
 
 
 

Intensive Course Track 2--Full Spectrum Distance-only Training

Click image to apply.
 
Phase 1:

(a) Attendance in a Web Conference Orientation session on Friday, November 14, 2014, (8:00-11:00 a.m. PT), and
 
(b) Complete 12 weeks of Distance Learning Modules with weekly Live Web-based discussion sessions every Friday morning (8:00-10:00 a.m. PT), and
 
(c) Participate in five (Live or Recorded) Working Group Case Conferences (Live Case Conferences are on Wednesdays, 10:00-11:30 a.m. PT), and
 
(d) Attend one Topics in Cancer Genetics Research (TOPICS) session (Fridays, 11:00 a.m.-12:00 noon)
 
Dates:  November 14, 2014 through February 20, 2015
 
Phase 2: (no on-campus workshops)
 

Phase 3:

Twelve months of self-directed continuing professional development and practice-centered support via Web Conference and Discussion Board activities. In addition, participants must present 1 case in Working Group and present once for TOPICS. 
 
 
Course requirements include:
 
  • Core Curriculum Modules:  3-4 assigned weekly
  • Pre-Post Case Scenarios
  • Pre-Post Course Knowledge Test
  • Weekly Friday review Web conferences
  • Five live or recorded Working Group case conferences
  • At least one Topics presentation
  • Pre-Post Surveys
  • Case Presentation (minimum of one risk assessment case from your practice)
  • Working Group Feedback Form (to accompany Working Group case conferencing)
  • 2 brief homework assignments (1 risk assessment, 1 Progeny pedigree drawing)
  • Prescribed Phase 3 Professional Development Activities (through 1 year post-course)
 
 
Fees:  (Payment is due on or before November 3, 2014)

MDs:  $1,600
RNs/GCs/Fellows/Pa-Cs:  $1,200
Industry:  $2,600
(Fees do not including travel or hotel)
 
 

Apply now: Intensive Course Application 2015 (The deadline to apply is August 1, 2014.)
 
 

Intensive Course Track 1: Full Spectrum Multi-modal Training

Click image to apply.
 
Phase 1:

(a) Attendance in a Web Conference Orientation session on Friday, November 14, 2014, (8:00-11:00 a.m. PT), and
 
(b) Complete 12 weeks of Distance Learning Modules with weekly Live Web-based discussion sessions every Friday morning (8:00-10:00 a.m. PT), and
 
(c) Participate in five (Live or Recorded) Working Group Case Conferences (Live Case Conferences are on Wednesdays, 10:00-11:30 a.m. PT), and
 
(d) Attend one Topics in Cancer Genetics Research (TOPICS) session (Fridays, 11:00 a.m.-12:00 noon)
 
Dates:  November 14, 2014 through February 20, 2015
 
Phase 2:

Four days of face-to-face Cancer Genetics Workshops on-campus at City of Hope in Duarte, CA.
 
Dates:  February 23 - 26, 2015
 
Phase 3:

Twelve months of self-directed continuing professional development and practice-centered support via Web Conference and Discussion Board activities. In addition, participants must present 1 case in Working Group and present once for TOPICS. 
 
 
Course requirements include:
 
  • Core Curriculum Modules:  3-4 assigned weekly
  • Pre-Post Case Scenarios
  • Pre-Post Course Knowledge Test
  • Weekly Friday review Web conferences
  • Five live or recorded Working Group case conferences
  • At least one Topics presentation
  • Pre-Post Surveys
  • Case Presentation (minimum of one risk assessment case from your practice)
  • Working Group Feedback Form (to accompany Working Group case conferencing)
  • 2 brief homework assignments (1 risk assessment, 1 Progeny pedigree drawing)
  • Prescribed Phase 3 Professional Development Activities (through 1 year post-course)
 
 
Fees:  (Payment is due on or before November 3, 2014)

MDs:  $2,000
RNs/GCs/Fellows/Pa-Cs:  $1,600
Industry:  $3,000
(Fees do not including travel or hotel)
 

Apply now:  Intensive Course Application 2015 (The deadline to apply is August 1, 2014.)
 
 

IC Tracks 3 & 4-Breast-Ovarian OR GI Sub-specialty Distance-only

Click image to apply.
 
Phase 1:

(a) Attendance in a Web Conference Orientation session on Friday, November 14, 2014, (8:00-11:00 a.m. PT), and
 
(b) Complete Distance Learning Modules (subset of full curriculum delivered over 12 weeks with Live Web-based discussion sessions Friday mornings (8:00-10:00 a.m. PT), and
 
(c) Participate in five (Live or Recorded) Working Group Case Conferences (Live Case Conferences are on Wednesdays, 10:00-11:30 a.m. PT), and
 
(d) Attend one Topics in Cancer Genetics Research (TOPICS) session (Fridays, 11:00 a.m.-12:00 noon)
 
Dates:  November 14, 2014 through February 20, 2015
 
Phase 2: (no on-campus workshops)
 
Phase 3:

Twelve months of self-directed continuing professional development and practice-centered support via Web Conference and Discussion Board activities. In addition, participants must present 1 case in Working Group and present once for TOPICS. 
 
 
Course requirements include:
 
  • Core Curriculum Modules:  3-4 assigned weekly
  • Pre-Post Case Scenarios
  • Pre-Post Course Knowledge Test
  • Weekly Friday review Web conferences
  • Five live or recorded Working Group case conferences
  • At least one Topics presentation
  • Pre-Post Surveys
  • Case Presentation (minimum of one risk assessment case from your practice)
  • Working Group Feedback Form (to accompany Working Group case conferencing)
  • 2 brief homework assignments (1 risk assessment, 1 Progeny pedigree drawing)
  • Prescribed Phase 3 Professional Development Activities (through 1 year post-course)
 
 
Fees:  (Payment is due on or before November 3, 2014)

MDs:  $1,600
RNs/GCs/Fellows/Pa-Cs:  $1,200
Industry:  $2,600
(Fees do not including travel or hotel)
 
 

Apply now:  Intensive Course Application 2015 (The deadline to apply is August 1, 2014.)
 
 
 
 

Clinical Cancer Genetics Community of Practice

City of Hope Clinical Cancer Genetics Community of Practice brings cancer genetics practitioners from diverse practice settings together for professional learning, enduring patient-centered support and dynamic community-based research collaborations to promote quality care and improved patient outcomes across the U.S. and internationally.
 
Working Group
 
Clinical Cancer Genetics (CCG) Working Group is a CME-accredited interdisciplinary cancer genetics case conference series conducted each week by the City of Hope clinical team.
 
TICGR Topics in Cancer Genetics Research
 
Topics in Clinical Cancer Genetics (TICGR) is a weekly one-hour CME-accredited web-conference seminar series focused on timely issues in clinical cancer genetics, cancer epidemiology and cancer genetics research, alternating between didactic lectures, case-based literature reviews and basic research journal club.
 

A Web-based discussion board for collaborative, interdisciplinary practice-based support and continuing professional learning.
 
Knowledge Center
 
Knowledge Center Information coming soon
 

A large research group of over 40 collaborating sites in the 40 collaborating sites in the United States, Mexico, and South America. As members of the CCGCRN, research collaborators can use the message board and forums to post questions and communicate with other members in the network.
 

Intensive Course

Intensive Course in Cancer Risk Assessment Overview

To help address the growing demand for clinicians with interdisciplinary knowledge and skills in the practice of genetic cancer risk assessment (GCRA), the multifaceted Intensive Course in Cancer Risk Assessment and its Clinical Cancer Genetics Community of Practice (CCGCoP) leverage the expertise of the academic health center through Web-based tools to deliver accessible, evidence-based cancer genetics and genomics training, professional development, and practice-centered support at the point of care. The mission of the Intensive Course and CCGCoP is to increase the number of clinicians who are able to translate rapid advances in genetics and genomics into cancer risk assessment, management, and prevention practice. Realizing the promise of personalized medicine by promoting best practices in the delivery of GCRA services across the U.S. and internationally is the ultimate goal of the Clinical Cancer Genetics Community of Practice.
 
 
Objectives
 
At the conclusion of the course the participants should be able to:
  • Integrate cancer genetics and oncology knowledge into clinical practice
  • Apply skills commensurate with practitioner-level proficiency into the cancer risk assessment and case management process
  • Recommend risk-appropriate options for cancer surveillance and prevention as part of the cancer risk assessment, including imaging, chemo preventive and surgical interventions
  • Incorporate understanding of medical, legal, and psychosocial ramifications of cancer risk counseling and testing into clinical practice and research collaboration
  • Discuss clinical research methodologies in cancer genetics epidemiology and cancer prevention trials for high-risk cohorts
  • Recognize the roles and practical issues related to Human Subjects Protections, Informed Consent, Institutional Review Board and HIPAA in clinical research
  • Provide resources and information on current hereditary cancer registries, cancer epidemiology and cancer prevention studies to patients and professional colleagues
  • Use research training and support to participate in collaborative research activities
  • Realize greater professional self-efficacy related to cancer risk counseling and research participation skills
  • Incorporate web-based resources into ongoing practice-based education, professional development and research network support
 
 
Reaching Clinicians Around the Globe
 
City of Hope's Intensive Course in Cancer Risk Assessment has trained health care professionals in community settings across the United States as well as in Argentina, Brazil, Canada, Chile, Columbia, Germany, Hong Kong, Mexico, Peru, Philippines, Puerto Rico, Spain, Taiwan, Turkey, and Uruguay. Participation of the Intensive Course alumni in the ongoing practice-centered professional development activities hosted by City of Hope has evolved into a dynamic international Clinical Cancer Genetics Community of Practice.
 
 

Accreditation

Accreditation

CME Credits
Accreditation Statement: Accreditation in process

Credit Designation: City of Hope designates this educational activity for a maximum of (TBD) AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The following may apply CME Category 1 credit for license renewal:

Registered Nurses: Nurses may report up to (TBD) credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). CME may be noted on the license renewal application in lieu of a BRN provider number.

Physician’s Assistants: The National Commission on Certification of Physician Assistants states that AMA accredited Category 1 courses are acceptable for CME requirements for recertification.

Genetic Counselor CEUs: The American Board of Genetic Counseling (ABGC) accepts CEUs approved by the National Society for Genetic Counselors (NSGC) for purposes of recertification. This event has been submitted to NSGC for approval of Category 1 CEUs and is approved for (TBD) CEUs and (TBD) Contact Hours.

Disclosure
The City of Hope adheres to ACCME Essential Areas, Standards for Commercial Support, and Policies regarding industry support of continuing medical education. Disclosure of the commercial relationships of everyone in a position to control content of an educational activity will be made at the activity. Speakers are also required to openly disclose discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
 
No partial credit will be given. Participants should claim only those hours of credit that they actually spent at the educational activity.
 

Application Requirement

Intensive Course Application Requirement

Click image to apply.
Application Deadline
 
Enrollment for the 2015 Winter course will begin on June 20, 2014. The deadline will be August 1, 2014.
 
Requirements
Please read all terms stated below before submitting application.

To receive full course credit, and certificate of course completion, course participants will be required to:
 
  • Participate in all distance and on-campus course related activities.
  • Complete all distance learning lecture modules delivered via Website and USB drive (flashdrive) interface by given deadlines.
  • Complete all pre- and post-course surveys, knowledge questionnaires, evaluations, and assignments as directed.
  • Agree to complete prescribed post-course professional development activities as outlined in the course syllabus. Some activities are required to be completed at 6-months post training and some must be completed by 1-year post training.
 
Selection Criteria
Preferred candidates are oncology or genetics-trained physicians, advanced practice nurses and genetic counselors currently providing or planning to initiate community-based clinical cancer genetics services.
 
 
How to Apply
 
Complete the Intensive Course Application and submit the following:
 
  • Completed application form
  • Letter from your institution indicating that protected time will be provided for course participation, and statement that you will have institutional support to provide cancer risk assessment upon return to your community (if applicable).
  • Current curriculum vitae (CV)
  • Mini-biography
  • Current headshot
 
Please NOTE: Applications will not be accepted without the items listed above.
 
Submit all of the above via regular mail, email or fax to:
 
Gloria Nuñez, Conference Coordinator
City of Hope
Division of Clinical Cancer Genetics, Mod 173
1500 East Duarte Road
Duarte, CA 91010-3000

Fax:
626-930-5495

Email:
gnunez@coh.org (note subject as "Intensive Course")
 
Acceptance
Applicants will be notified of acceptance by September 30, 2014, via e-mail. The non-refundable course fee (TBD) will be due on or before October 31, 2014.
 

Faculty

Faculty

Course Co-directors
Jeffrey Weitzel, M.D.
Director, Division of Clinical Cancer Genetics
and
Kathleen R. Blazer, Ed.D., M.S., L.C.G.C.
Assistant Director, Cancer Genetics Education Program

City of Hope Faculty
Danielle Castillo, BS
Cathy Cole, RNC, NP, MPH
Josef Herzog, BS
Robert Morgan, Jr., MD, FACP
Bita Nehoray, MS, LCGC
Mariana Niell-Swiller, MS, CGC
Lacolle Robinson, BA
Sharon Sand, BA, CCRP
Ilana Solomon, ScM, MS, CGC
April Sorrell, MD
Sharon Wilczynski, MD, PhD

Guest Faculty
Kimberly Banks, MS, CGC, Ambry Genetics
Julie Culver, MS, LCGC, USC Norris Comprehensive Cancer Center
Allan Ebbin, MD, MPH, UnitedHealthcare (retired)
Carin Espenschied, MS, LCGC, Ambry Genetics
Carol Fabian, MD, University of Kansas Cancer Breast Cancer Prevention and Survivorship Centers
Lucille Leong, MD, City of Hope
Katrina Lowstuter, MS, CGC, USC Norris Comprehensive Cancer Center
Deborah J. MacDonald, PhD, RN, APNG, (former CCG faculty)
Hazel Mariveles, BS, (former CCG staff)
Susan Neuhausen, PhD, University of California Irvine
Gloria Petersen, PhD, Mayo Clinic
Charité Ricker, MS, CGC, LAC+USC Medical Center

Administrative Staff
Gloria Nuñez, Conference Coordinator
Stacy Berger, Programmer Analyst
Larry Kiang, Technology Specialist
Tracy Sulkin, Education Assistant

Intensive Course Alumni

Intensive Course Alumni

City of Hope's Intensive Course in Cancer Risk Assessment has trained health professionals in community settings across the United States as well as in Argentina, Brazil, Canada, Chile, Columbia, Germany, Hong Kong, Mexico, Peru, Philippines, Puerto Rico, Spain, Taiwan, Turkey, and Uruguay.

Intensive Course Description

Intensive Course Description

The Intensive Course and Clinical Cancer Genetics Community of Practice embody the tenets of practice-centered situated learning theory. Distance delivery of a modular curriculum responds to the practical time constraints of working clinicians and allows for flexible, self-directed study (e.g., oncologists can opt out of basic oncology content and focus more study time on genetics content, etc.). Concurrent participation in Working Group Clinical Cancer Genetics Web conferences reinforces didactic learning and Genetic Cancer Risk Assessment (GCRA) skills development. Participants have the option of participating in one of four training tracks to customize training to meet their learning needs.
 
 
Click the individual track link below for more information, including fees, and to download the track Calendar for 2015 Winter (calendar in progress).
 
 
All four tracks include distance didactic learning with corresponding Web conference reviews, and case-based training with Working Group Web conferences. Only Track 1 Full Spectrum Multi-modal Training includes four days of face-to-face program development workshops.
 
Upon completion of training, all participants receive support to apply new learning to practice through 12 months of self-directed engagement and activities as members of the Clinical Cancer Genetics Community of Practice.
 
 
 

Full Spectrum Distance-only Training

Intensive Course Track 2--Full Spectrum Distance-only Training

Click image to apply.
 
Phase 1:

(a) Attendance in a Web Conference Orientation session on Friday, November 14, 2014, (8:00-11:00 a.m. PT), and
 
(b) Complete 12 weeks of Distance Learning Modules with weekly Live Web-based discussion sessions every Friday morning (8:00-10:00 a.m. PT), and
 
(c) Participate in five (Live or Recorded) Working Group Case Conferences (Live Case Conferences are on Wednesdays, 10:00-11:30 a.m. PT), and
 
(d) Attend one Topics in Cancer Genetics Research (TOPICS) session (Fridays, 11:00 a.m.-12:00 noon)
 
Dates:  November 14, 2014 through February 20, 2015
 
Phase 2: (no on-campus workshops)
 

Phase 3:

Twelve months of self-directed continuing professional development and practice-centered support via Web Conference and Discussion Board activities. In addition, participants must present 1 case in Working Group and present once for TOPICS. 
 
 
Course requirements include:
 
  • Core Curriculum Modules:  3-4 assigned weekly
  • Pre-Post Case Scenarios
  • Pre-Post Course Knowledge Test
  • Weekly Friday review Web conferences
  • Five live or recorded Working Group case conferences
  • At least one Topics presentation
  • Pre-Post Surveys
  • Case Presentation (minimum of one risk assessment case from your practice)
  • Working Group Feedback Form (to accompany Working Group case conferencing)
  • 2 brief homework assignments (1 risk assessment, 1 Progeny pedigree drawing)
  • Prescribed Phase 3 Professional Development Activities (through 1 year post-course)
 
 
Fees:  (Payment is due on or before November 3, 2014)

MDs:  $1,600
RNs/GCs/Fellows/Pa-Cs:  $1,200
Industry:  $2,600
(Fees do not including travel or hotel)
 
 

Apply now: Intensive Course Application 2015 (The deadline to apply is August 1, 2014.)
 
 

Full Spectrum Multi-modal Training

Intensive Course Track 1: Full Spectrum Multi-modal Training

Click image to apply.
 
Phase 1:

(a) Attendance in a Web Conference Orientation session on Friday, November 14, 2014, (8:00-11:00 a.m. PT), and
 
(b) Complete 12 weeks of Distance Learning Modules with weekly Live Web-based discussion sessions every Friday morning (8:00-10:00 a.m. PT), and
 
(c) Participate in five (Live or Recorded) Working Group Case Conferences (Live Case Conferences are on Wednesdays, 10:00-11:30 a.m. PT), and
 
(d) Attend one Topics in Cancer Genetics Research (TOPICS) session (Fridays, 11:00 a.m.-12:00 noon)
 
Dates:  November 14, 2014 through February 20, 2015
 
Phase 2:

Four days of face-to-face Cancer Genetics Workshops on-campus at City of Hope in Duarte, CA.
 
Dates:  February 23 - 26, 2015
 
Phase 3:

Twelve months of self-directed continuing professional development and practice-centered support via Web Conference and Discussion Board activities. In addition, participants must present 1 case in Working Group and present once for TOPICS. 
 
 
Course requirements include:
 
  • Core Curriculum Modules:  3-4 assigned weekly
  • Pre-Post Case Scenarios
  • Pre-Post Course Knowledge Test
  • Weekly Friday review Web conferences
  • Five live or recorded Working Group case conferences
  • At least one Topics presentation
  • Pre-Post Surveys
  • Case Presentation (minimum of one risk assessment case from your practice)
  • Working Group Feedback Form (to accompany Working Group case conferencing)
  • 2 brief homework assignments (1 risk assessment, 1 Progeny pedigree drawing)
  • Prescribed Phase 3 Professional Development Activities (through 1 year post-course)
 
 
Fees:  (Payment is due on or before November 3, 2014)

MDs:  $2,000
RNs/GCs/Fellows/Pa-Cs:  $1,600
Industry:  $3,000
(Fees do not including travel or hotel)
 

Apply now:  Intensive Course Application 2015 (The deadline to apply is August 1, 2014.)
 
 

Breast-Ovarian OR G.I. Sub-specialty Training

IC Tracks 3 & 4-Breast-Ovarian OR GI Sub-specialty Distance-only

Click image to apply.
 
Phase 1:

(a) Attendance in a Web Conference Orientation session on Friday, November 14, 2014, (8:00-11:00 a.m. PT), and
 
(b) Complete Distance Learning Modules (subset of full curriculum delivered over 12 weeks with Live Web-based discussion sessions Friday mornings (8:00-10:00 a.m. PT), and
 
(c) Participate in five (Live or Recorded) Working Group Case Conferences (Live Case Conferences are on Wednesdays, 10:00-11:30 a.m. PT), and
 
(d) Attend one Topics in Cancer Genetics Research (TOPICS) session (Fridays, 11:00 a.m.-12:00 noon)
 
Dates:  November 14, 2014 through February 20, 2015
 
Phase 2: (no on-campus workshops)
 
Phase 3:

Twelve months of self-directed continuing professional development and practice-centered support via Web Conference and Discussion Board activities. In addition, participants must present 1 case in Working Group and present once for TOPICS. 
 
 
Course requirements include:
 
  • Core Curriculum Modules:  3-4 assigned weekly
  • Pre-Post Case Scenarios
  • Pre-Post Course Knowledge Test
  • Weekly Friday review Web conferences
  • Five live or recorded Working Group case conferences
  • At least one Topics presentation
  • Pre-Post Surveys
  • Case Presentation (minimum of one risk assessment case from your practice)
  • Working Group Feedback Form (to accompany Working Group case conferencing)
  • 2 brief homework assignments (1 risk assessment, 1 Progeny pedigree drawing)
  • Prescribed Phase 3 Professional Development Activities (through 1 year post-course)
 
 
Fees:  (Payment is due on or before November 3, 2014)

MDs:  $1,600
RNs/GCs/Fellows/Pa-Cs:  $1,200
Industry:  $2,600
(Fees do not including travel or hotel)
 
 

Apply now:  Intensive Course Application 2015 (The deadline to apply is August 1, 2014.)
 
 
 
 

CCG Community of Practice

Clinical Cancer Genetics Community of Practice

City of Hope Clinical Cancer Genetics Community of Practice brings cancer genetics practitioners from diverse practice settings together for professional learning, enduring patient-centered support and dynamic community-based research collaborations to promote quality care and improved patient outcomes across the U.S. and internationally.
 
Working Group
 
Clinical Cancer Genetics (CCG) Working Group is a CME-accredited interdisciplinary cancer genetics case conference series conducted each week by the City of Hope clinical team.
 
TICGR Topics in Cancer Genetics Research
 
Topics in Clinical Cancer Genetics (TICGR) is a weekly one-hour CME-accredited web-conference seminar series focused on timely issues in clinical cancer genetics, cancer epidemiology and cancer genetics research, alternating between didactic lectures, case-based literature reviews and basic research journal club.
 

A Web-based discussion board for collaborative, interdisciplinary practice-based support and continuing professional learning.
 
Knowledge Center
 
Knowledge Center Information coming soon
 

A large research group of over 40 collaborating sites in the 40 collaborating sites in the United States, Mexico, and South America. As members of the CCGCRN, research collaborators can use the message board and forums to post questions and communicate with other members in the network.
 
Clinical Cancer Genetics
The City of Hope Division of Clinical Cancer Genetics is committed to being a national leader in the advancement of cancer genetics, screening and prevention, through innovative patient care, research and education.

Contact Us
  • 800-826-HOPE (4673)
  • For more information about the Cancer Screening & Prevention Program, call 626-256-8662, ext. 2.
Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
City of Hope Breakthroughs
Get the latest in City of Hope's research, treatment and news you can use on our blog, Breakthroughs.
 
 


NEWS & UPDATES
  • Joselyn Miller received a lifesaving bone marrow transplant at City of Hope two years ago. Here, she reflects on her gratitude as a bone marrow recipient and on giving back. By Joselyn Miller thank•ful adjective  \ˈthaŋk-fəl\ :  conscious of benefit received :  glad that something has happened or not happened, ...
  • When it comes to cancer, your family history may provide more questions than answers: How do my genes increase my risk for cancer? No one in my family has had cancer; does that mean I won’t get cancer? What cancers are common in certain populations and ethnicities? City of Hope experts have some guidance. “Your...
  • The body’s immune system is usually adept at attacking outside invaders such as bacteria and viruses. But because cancer originates from the body’s own cells, the immune system can fail to see it as foreign. As a result, the body’s most powerful ally can remain largely idle against cancer as the disease progres...
  • On Jan. 1, 2015, five City of Hope patients who have journeyed through cancer will welcome the new year with their loved ones atop City of Hope’s Tournament of Roses Parade float. The theme of the float is “Made Possible by HOPE.” The theme of the parade is “Inspiring Stories.” Her...
  • Are you thinking about switching from traditional cigarettes to e-cigarettes for the Great American Smokeout? Are you thinking that might be a better option than the traditional quit-smoking route? Think again. For lung expert Brian Tiep, M.D., the dislike and distrust he feels for e-cigs comes down to this: Th...
  • Hematologist Robert Chen, M.D., is boosting scientific discovery at City of Hope and, by extension, across the nation. Just ask the National Cancer Institute. The institution recently awarded Chen the much-sought-after Clinical Investigator Team Leadership Award for boosting scientific discovery at City of Hope...
  • Great strides have been made in treating cancer – including lung cancer – but by the time people show symptoms of the disease, the cancer has usually advanced. That’s because, at early stages, lung cancer has no symptoms. Only recently has lung cancer screening become an option. (Read more about the risks...
  • Identifying cures for currently incurable diseases and providing patients with safe, fast and potentially lifesaving treatments is the focus of City of Hope’s new Alpha Clinic for Cell Therapy and Innovation (ACT-I). The clinic is funded by an $8 million, five-year grant from the California Institute for Regene...
  • Cancer is a couple’s disease. It affects not just the person diagnosed, but his or her partner as well. It also affects the ability of both people to communicate effectively. The Couples Coping with Cancer Together program at City of Hope teaches couples how to communicate and solve problems as a unit. He...
  • Chemotherapy drugs work by either killing cancer cells or by stopping them from multiplying, that is, dividing. Some of the more powerful drugs used to treat cancer do their job by interfering with the cancer cells’ DNA and RNA growth, preventing them from copying themselves and dividing. Such drugs, however, l...
  • During October, everything seems to turn pink – clothing, the NFL logo, tape dispensers, boxing gloves, blenders, soup cans, you name it – in order to raise awareness for what many believe is the most dangerous cancer that affects women: breast cancer. But, in addition to thinking pink, women should...
  • In February 2003, when she was only 16 months old, Maya Gallardo was diagnosed with acute myelogenous leukemia (AML) and, to make matters much worse, pneumonia. The pneumonia complicated what was already destined to be grueling treatment regimen. To assess the extent of her illness, Maya had to endure a spinal ...
  • Former smokers age 55 to 74 who rely on Medicare for health care services have just received a long-hoped-for announcement. Under a proposed decision from the Centers for Medicare and Medicaid Services, they’ll now have access to lung cancer screening with a low-dose CT scan. The proposed decision, announ...
  • City of Hope has a longstanding commitment to combating diabetes, a leading national and global health threat. Already, it’s scored some successes, from research that led to the development of synthetic human insulin – still used by millions of patients – to potentially lifesaving islet cell transplants. Diabet...
  • Dee Hunt never smoked. Neither did her five sisters and brothers. They didn’t have exposure to radon or asbestos, either. That didn’t prevent every one of them from being diagnosed with lung cancer. Their parents were smokers, but they’d all left home more than 30 years before any of them were diagn...